Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Doxorubicin Market Report by Application (Breast Cancer, Ovarian Cancer, Multiple Myeloma, Kaposi Sarcoma, Leukemia, Bone Sarcoma, Endometrial Cancer, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Stores, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A5677
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Doxorubicin Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Application
6.1 Breast Cancer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Ovarian Cancer
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Multiple Myeloma
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Kaposi Sarcoma
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Leukemia
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Bone Sarcoma
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Endometrial Cancer
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Hospital and Retail Pharmacies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Online Stores
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Accord Healthcare Ltd. (Intas Pharmaceuticals Limited)
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.2 Baxter International Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Cadila Pharmaceuticals
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Cipla Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Hikma Pharmaceuticals PLC
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 Meiji Holdings Co. Ltd.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Novartis AG
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Pfizer Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
List of Figures
Figure 1: Global: Doxorubicin Market: Major Drivers and Challenges
Figure 2: Global: Doxorubicin Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Doxorubicin Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Doxorubicin Market: Breakup by Application (in %), 2023
Figure 5: Global: Doxorubicin Market: Breakup by Distribution Channel (in %), 2023
Figure 6: Global: Doxorubicin Market: Breakup by Region (in %), 2023
Figure 7: Global: Doxorubicin (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 8: Global: Doxorubicin (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 9: Global: Doxorubicin (Ovarian Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Doxorubicin (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Doxorubicin (Multiple Myeloma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Doxorubicin (Multiple Myeloma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Doxorubicin (Kaposi Sarcoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Doxorubicin (Kaposi Sarcoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Doxorubicin (Leukemia) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Doxorubicin (Leukemia) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Doxorubicin (Bone Sarcoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Doxorubicin (Bone Sarcoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Doxorubicin (Endometrial Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Doxorubicin (Endometrial Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Doxorubicin (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Doxorubicin (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Doxorubicin (Hospital and Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Doxorubicin (Hospital and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Doxorubicin (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Doxorubicin (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Doxorubicin (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Doxorubicin (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: North America: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: North America: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: United States: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: United States: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Canada: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Canada: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Asia-Pacific: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Asia-Pacific: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: China: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: China: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Japan: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Japan: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: India: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: India: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: South Korea: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: South Korea: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Australia: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Australia: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Indonesia: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Indonesia: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Others: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Others: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Europe: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Europe: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Germany: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Germany: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: France: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: France: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: United Kingdom: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: United Kingdom: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Italy: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Italy: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Spain: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Spain: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Russia: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Russia: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Others: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Others: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Latin America: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Latin America: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Brazil: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Brazil: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Mexico: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Mexico: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Middle East and Africa: Doxorubicin Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Middle East and Africa: Doxorubicin Market: Breakup by Country (in %), 2023
Figure 77: Middle East and Africa: Doxorubicin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Global: Doxorubicin Industry: SWOT Analysis
Figure 79: Global: Doxorubicin Industry: Value Chain Analysis
Figure 80: Global: Doxorubicin Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Doxorubicin Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Doxorubicin Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 3: Global: Doxorubicin Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 4: Global: Doxorubicin Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 5: Global: Doxorubicin Market: Competitive Structure
Table 6: Global: Doxorubicin Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More